Cadre of gene-edit­ing biotechs ral­ly against al­ter­ing DNA that could af­fect fu­ture gen­er­a­tions

A con­tin­gent of biotechs have joined the clar­i­on call against germline gene edit­ing, cit­ing un­re­solved safe­ty, eth­i­cal, le­gal and so­ci­etal is­sues in this type of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER